Leaflet DICYNONE 250mg tablets
Indicated for: bleeding; coagulation disorders
Route of administration: oral
Substance: etamsylate (anticoagulant)
ATC: B02BX01 (Blood and blood forming organs | Vitamin k and other hemostatics | Other systemic hemostatics)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Etamsylate is a medication used to stop or prevent bleeding, recommended in various situations such as surgical interventions, nosebleeds, heavy menstruation, or other conditions involving vascular fragility. It works by increasing capillary resistance and stimulating platelet formation, thus helping to stop bleeding.
Etamsylate is administered orally as tablets or by injection, depending on the severity of the situation and the doctor's recommendation. The dose and duration of treatment are determined individually, according to each patient's needs.
Side effects may include mild digestive disorders, allergic reactions, headaches, or, rarely, low blood pressure. In general, etamsylate is well tolerated, but it is important that the treatment is followed under medical supervision.
Etamsylate is an effective solution for controlling bleeding, being useful both in emergencies and in preventing recurrences in patients at high risk of hemorrhage.
General data about DICYNONE 250mg
- Substance: etamsylate
- Date of latest medicines list: 01-07-2013
- Product code: W56873001
- Concentration: 250mg
- Pharmaceutical form: tablets
- Quantity: 20
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for etamsylate
Concentrations available for etamsylate
- 125mg/ml
- 250mg
- 250mg/2ml